Latest Insider Transactions at Apollo Endosurgery, Inc. (APEN)
This section provides a real-time view of insider transactions for Apollo Endosurgery, Inc. (APEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Apollo Endosurgery, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Apollo Endosurgery, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
128,585
+8.82%
|
-
|
|
May 21
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,609
+1.88%
|
-
|
|
May 21
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
8,045
+1.92%
|
-
|
|
May 19
2021
|
David Pacitti Director |
SELL
Open market or private sale
|
Direct |
18,742
-20.22%
|
$112,452
$6.81 P/Share
|
|
Apr 05
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
303
+0.08%
|
$1,515
$5.48 P/Share
|
|
Mar 10
2021
|
John J Molesphini EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
14,028
+15.69%
|
-
|
|
Mar 10
2021
|
Bret Schwartzhoff VP, US Sales & Marketing |
BUY
Grant, award, or other acquisition
|
Direct |
14,028
+12.0%
|
-
|
|
Mar 10
2021
|
Chas Mc Khann President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
707,278
+50.0%
|
-
|
|
Mar 10
2021
|
Christopher J. Gostout Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,020
+11.47%
|
-
|
|
Mar 10
2021
|
John R Barr Director |
BUY
Open market or private purchase
|
Direct |
10,000
+5.97%
|
$50,000
$5.88 P/Share
|
|
Mar 10
2021
|
Stefanie L. Cavanaugh CFO, Treasurer, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
14,028
+12.76%
|
-
|
|
Feb 24
2021
|
Sciences Ii L P Ptv > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,972,805
-87.5%
|
-
|
|
Feb 24
2021
|
Sciences Ii L P Ptv > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
19,528
+50.0%
|
-
|
|
Feb 24
2021
|
Matthew S Crawford > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
6,461
+2.36%
|
-
|
|
Feb 24
2021
|
Matthew S Crawford > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,972,805
-87.5%
|
-
|
|
Feb 24
2021
|
Matthew S Crawford > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
19,528
+50.0%
|
-
|
|
Feb 23
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,166
+13.61%
|
$16,664
$4.62 P/Share
|
|
Feb 23
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,055
+1.96%
|
$32,220
$4.62 P/Share
|
|
Feb 22
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,103
+2.5%
|
$40,412
$4.8 P/Share
|
|
Feb 18
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,649
+0.43%
|
$6,596
$4.75 P/Share
|
|
Feb 18
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
378
+1.67%
|
$1,512
$4.75 P/Share
|
|
Feb 05
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,589
+18.12%
|
$90,356
$4.99 P/Share
|
|
Feb 05
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
30,954
+7.49%
|
$123,816
$4.71 P/Share
|
|
Feb 04
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,729
+8.8%
|
$38,916
$4.71 P/Share
|
|
Feb 03
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
28,388
+12.31%
|
$113,552
$4.48 P/Share
|
|
Feb 02
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,873
+14.74%
|
$43,492
$4.42 P/Share
|
|
Feb 01
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
473
+0.13%
|
$1,892
$4.2 P/Share
|
|
Jan 06
2021
|
Stefanie L. Cavanaugh CFO, Treasurer, Secretary |
BUY
Other acquisition or disposition
|
Direct |
218
+0.27%
|
-
|
|
Jan 05
2021
|
Todd Newton Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
3,479
+0.84%
|
-
|
|
Dec 16
2020
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private sale
|
Direct |
8,314
+2.31%
|
$33,256
$4.16 P/Share
|
|
Dec 16
2020
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private sale
|
Indirect |
2,488
+14.51%
|
$9,952
$4.16 P/Share
|
|
Oct 30
2020
|
Sciences Ii L P Ptv > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,715,928
-100.0%
|
-
|
|
Oct 30
2020
|
Sciences Ii L P Ptv > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
857,964
+50.0%
|
-
|
|
Oct 30
2020
|
Matthew S Crawford > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,715,928
+45.63%
|
-
|
|
Oct 30
2020
|
Matthew S Crawford > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
857,964
-87.02%
|
-
|
|
Oct 30
2020
|
Matthew S Crawford > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
857,964
+46.53%
|
-
|
|
Oct 30
2020
|
Matthew S Crawford > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,715,928
-100.0%
|
-
|
|
Oct 28
2020
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private sale
|
Indirect |
10,356
+1.06%
|
$10,356
$1.65 P/Share
|
|
Jul 17
2020
|
Cpmg Inc |
BUY
Open market or private purchase
|
Indirect |
1,780,000
+39.24%
|
$1,780,000
$1.25 P/Share
|
|
Jan 02
2020
|
Cpmg Inc |
BUY
Other acquisition or disposition
|
Indirect |
57,163
+19.42%
|
-
|